224 related articles for article (PubMed ID: 25125080)
21. Potent inhibitor of N-myristoylation: a novel molecular target for cancer.
Shrivastav A; Pasha MK; Selvakumar P; Gowda S; Olson DJ; Ross AR; Dimmock JR; Sharma RK
Cancer Res; 2003 Nov; 63(22):7975-8. PubMed ID: 14633729
[TBL] [Abstract][Full Text] [Related]
22. Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites.
Olaleye TO; Brannigan JA; Roberts SM; Leatherbarrow RJ; Wilkinson AJ; Tate EW
Org Biomol Chem; 2014 Nov; 12(41):8132-7. PubMed ID: 25230674
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and antifungal activity of isosteric analogues of benzoheterocyclic N-myristoyltransferase inhibitors.
Sheng C; Xu H; Wang W; Cao Y; Dong G; Wang S; Che X; Ji H; Miao Z; Yao J; Zhang W
Eur J Med Chem; 2010 Sep; 45(9):3531-40. PubMed ID: 20615585
[TBL] [Abstract][Full Text] [Related]
24. Development of an enzyme-linked immunosorbent assay for measurement of activity of myristoyl-coenzyme A:protein N-myristoyltransferase.
Takamune N; Hamada H; Sugawara H; Misumi S; Shoji S
Anal Biochem; 2002 Oct; 309(1):137-42. PubMed ID: 12381372
[TBL] [Abstract][Full Text] [Related]
25. Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major.
Panethymitaki C; Bowyer PW; Price HP; Leatherbarrow RJ; Brown KA; Smith DF
Biochem J; 2006 Jun; 396(2):277-85. PubMed ID: 16480339
[TBL] [Abstract][Full Text] [Related]
26. Coenzyme A dependent myristoylation and demyristoylation in the regulation of bovine spleen N-myristoyltransferase.
Raju RV; Sharma RK
Mol Cell Biochem; 1996 May; 158(2):107-13. PubMed ID: 8817471
[TBL] [Abstract][Full Text] [Related]
27. Effects of L-histidine and its structural analogues on human N-myristoyltransferase activity and importance of EEVEH amino acid sequence for enzyme activity.
Raju RV; Datla RS; Warrington RC; Sharma RK
Biochemistry; 1998 Oct; 37(42):14928-36. PubMed ID: 9778369
[TBL] [Abstract][Full Text] [Related]
28. N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.
Frearson JA; Brand S; McElroy SP; Cleghorn LA; Smid O; Stojanovski L; Price HP; Guther ML; Torrie LS; Robinson DA; Hallyburton I; Mpamhanga CP; Brannigan JA; Wilkinson AJ; Hodgkinson M; Hui R; Qiu W; Raimi OG; van Aalten DM; Brenk R; Gilbert IH; Read KD; Fairlamb AH; Ferguson MA; Smith DF; Wyatt PG
Nature; 2010 Apr; 464(7289):728-32. PubMed ID: 20360736
[TBL] [Abstract][Full Text] [Related]
29. N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence.
Maurer-Stroh S; Eisenhaber B; Eisenhaber F
J Mol Biol; 2002 Apr; 317(4):541-57. PubMed ID: 11955008
[TBL] [Abstract][Full Text] [Related]
30. Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent.
Lodge JK; Jackson-Machelski E; Higgins M; McWherter CA; Sikorski JA; Devadas B; Gordon JI
J Biol Chem; 1998 May; 273(20):12482-91. PubMed ID: 9575206
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of action of NIP71 on N-myristoyltransferase activity.
King MJ; Sharma RK
Mol Cell Biochem; 1994 Dec; 141(2):79-86. PubMed ID: 7891674
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and biochemical characterization of bovine spleen myristoyl CoA:protein N-myristoyltransferase.
Raju RV; Anderson JW; Datla RS; Sharma RK
Arch Biochem Biophys; 1997 Dec; 348(1):134-42. PubMed ID: 9390183
[TBL] [Abstract][Full Text] [Related]
33. [Evolutionary trace analysis of N-myristoyltransferase family].
Sheng CQ; Zhu J; Zhang WN; Xu H; Miao ZY; Yao JZ; Zhang M
Yao Xue Xue Bao; 2007 Feb; 42(2):157-65. PubMed ID: 17518043
[TBL] [Abstract][Full Text] [Related]
34. Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase.
Nagarajan SR; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Mehta PP; Kishore NS; McWherter CA; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 May; 40(10):1422-38. PubMed ID: 9154965
[TBL] [Abstract][Full Text] [Related]
35. Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-terminal region.
Wu J; Tao Y; Zhang M; Howard MH; Gutteridge S; Ding J
J Biol Chem; 2007 Jul; 282(30):22185-94. PubMed ID: 17513302
[TBL] [Abstract][Full Text] [Related]
36. N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action.
Schlott AC; Holder AA; Tate EW
ACS Infect Dis; 2018 Apr; 4(4):449-457. PubMed ID: 29363940
[TBL] [Abstract][Full Text] [Related]
37. Regulation of N-myristoyltransferase by novel inhibitor proteins.
Shrivastav A; Selvakumar P; Bajaj G; Lu Y; Dimmock JR; Sharma RK
Cell Biochem Biophys; 2005; 43(1):189-202. PubMed ID: 16043893
[TBL] [Abstract][Full Text] [Related]
38. Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl CoA:protein N-myristoyltransferase.
Paige LA; Zheng GQ; DeFrees SA; Cassady JM; Geahlen RL
Biochemistry; 1990 Nov; 29(46):10566-73. PubMed ID: 2271666
[TBL] [Abstract][Full Text] [Related]
39. N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections.
Kosciuk T; Lin H
ACS Chem Biol; 2020 Jul; 15(7):1747-1758. PubMed ID: 32453941
[TBL] [Abstract][Full Text] [Related]
40. Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode.
Spinks D; Smith V; Thompson S; Robinson DA; Luksch T; Smith A; Torrie LS; McElroy S; Stojanovski L; Norval S; Collie IT; Hallyburton I; Rao B; Brand S; Brenk R; Frearson JA; Read KD; Wyatt PG; Gilbert IH
ChemMedChem; 2015 Nov; 10(11):1821-36. PubMed ID: 26395087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
